Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs
- 8 January 2002
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 26 (3), 311-316
- https://doi.org/10.1016/s0145-2126(01)00118-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuliOncogene, 1999
- Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosisOncogene, 1999
- Bcl-xL Modulates Apoptosis Induced by Anticancer Drugs and Delays DEVDase and DNA Fragmentation-Promoting ActivitiesExperimental Cell Research, 1998
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group StudyBlood, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.The Journal of Immunology, 1995
- Expression of bcl-xL can confer a multidrug resistance phenotypeBlood, 1995